A seasoned healthcare investor and operator, Simon has spent close to 20 years at Roche, including 15 years with the Roche Venture Fund, where he invested in biotech, diagnostics, and digital health opportunities and served on boards across the US and Europe.
He also built and led a Business Development and Partnering organisation for one of Roche’s digital business areas, advancing global strategies and collaborations with GE HealthCare, Accenture, Microsoft, IBM, and Amazon Web Services (AWS).
Beyond his corporate experience, Simon actively supports early-stage startups, holding board roles and serving on an Investment Committee for a corporate VC fund.
At OXcan, Simon brings a unique blend of investor insight, operational discipline, and partnership-building expertise that will be instrumental in driving our next phase of growth. His proven ability to bridge innovation and execution will strengthen our global collaborations and help accelerate the translation of science into real-world impact.
Simon holds a lic. oec. HSG from the University of St.Gallen (Finance & Capital Markets) and is pursuing advanced board certification through the Swiss Board School.
We’re thrilled to welcome Simon to OXcan as we continue advancing our mission to transform diagnostics and enable better health outcomes through innovation.